Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end ...

There are a lot of reasons why Tottenham Hotspur, despite a wretched Premier League campaign, roared back to win the Europa ...

Tottenham Hotspur’s Argentine defender Cristian Romero is understandably on the radar of Europe’s top clubs, with particular ...

Tottenham emerged victorious at San Mamés in the Europa League final not just because of Manchester United’s disjointed ...

Europa League Final not only crowned a new champion—it also delivered a fiery showdown between two tough defenders: Cristian ...

The English defender has had a great season with the Spurs, and his leadership on the field has not gone unnoticed. Tottenham ...

GSK & Spero Therapeutics announce PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by IDMC: London, UK Friday, May 30, 2025, 15:00 Hrs [IST] ...

Tottenham will return to the Champions League, and Cuti celebrated it with pure joy. But as the cameras captured his tears, ...

In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral ...

"Complicated UTIs can have a profound impact on patients and carry a high risk of clinical complications, including sepsis and septic shock," said GSK Chief Scientific Officer Tony Wood. "These ...